Clinical Trials Search | Clareo Health

Showing 1-1 of 1 trials

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

NCT06510374

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ferring Pharmaceuticals454 participantsStarted Oct 2024

Mobile, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +76 more locations

Data from ClinicalTrials.govTerms

Filters

Filters

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer